News

Phytomedics has published the results of a six month, phase 2b clinical trial with an extract of Tripterygium wilfordii Hook F (TwHF) in August 18, 2009 issue of

The FDA has approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by

Gentium has reported top-line results from a historically controlled, multicenter, open label, phase III trial, designed to evaluate the safety and efficacy of 25mg/kg/day of Defibrotide. The study

Cerus has reported that the Swiss regulatory body, Swissmedic, has approved the use of platelet components treated with Cerus’ Intercept Blood System. The approval extends permitted storage time

Czech Republic-based contract manufacturing organisation, Medis International has completed construction of its new 2,700sqm pharma packaging plant in Bolatice, reported in-Pharma Technologist. Reportedly, the company officials said that

Unichem Laboratories has received FDA approval for bisoprolol fumarate tablets, for strengths of 5mg and 10mg. Bisoprolol fumerage tablets are therapeutically equivalent to Duramed Pharmaceuticals’ Zebeta tablets. The

Advaxis has formed a collaboration with investigators at City of Hope. It is for the development of a vaccine to treat certain forms of leukemia and lymphoma, based

Nycomed has reported sustained momentum in the second quarter of 2009, with total net turnover increasing by 0.5% to E786.9m for the first half of 2008. Adjusted EBITDA

Entest BioMedical, a subsidiary of Bio-Matrix Scientific (BMSN), has filed a patent application for the use of adipose derived stem cells in the treatment of Chronic Obstructive Pulmonary